{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5079, "recent_count": 5, "transaction_limit": 160, "filters": {"q": "", "ticker": "NKTR", "sector": "", "industry": "", "side": "", "start": "2026-06-17", "end": "2026-08-01"}, "summary": {"total": 5, "acquisition_count": 2, "disposal_count": 3, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 1009550.0, "disposal_value_label": "$1.0M", "net_value": -1009550.0, "net_value_label": "$-1.0M", "flow_tone": "negative", "largest_value_label": "$397.7K", "top_sector": "Healthcare", "window_label": "17 Jun 2026 to 01 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 5, "value": "1009550.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$1.0M"}], "days": [{"transaction_date": "2026-06-17", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 100.0}, {"transaction_date": "2026-06-30", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 50.0}, {"transaction_date": "2026-07-24", "acquisitions": 2, "disposals": 0, "total": 2, "bar_width": 100.0}], "side_mix": {"acquisitions": 2, "disposals": 3, "acquisition_share": 40.0, "disposal_share": 60.0}}, "company_flows": [{"symbol": "NKTR", "name": "Nektar Therapeutics", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "acquisitions": 2, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1009550.0, "disposed_value_label": "$1.0M", "net_value": -1009550.0, "net_value_label": "$-1.0M", "acquisition_share": 40.0, "disposal_share": 60.0, "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}], "company_overview": [{"symbol": "NKTR", "name": "Nektar Therapeutics", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-24", "filings": 5, "acquisitions": 2, "disposals": 3, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 1009550.0, "disposed_value_label": "$1.0M", "net_value": -1009550.0, "net_value_label": "$-1.0M", "acquisition_share": 40.0, "disposal_share": 60.0, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}], "transactions": [{"symbol": "NKTR", "name": "Nektar Therapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "ROBIN, HOWARD W", "executive_title": "Director, President & CEO", "security_type": "Stock Option", "side_code": "A", "side": "Acquisition", "shares": 57200.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:09:00.627652+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}, {"symbol": "NKTR", "name": "Nektar Therapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-24", "executive": "ZALEVSKY, JONATHAN", "executive_title": "Chief R&D Officer", "security_type": "Stock Option", "side_code": "A", "side": "Acquisition", "shares": 16500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-30T22:09:00.616325+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}, {"symbol": "NKTR", "name": "Nektar Therapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "ZALEVSKY, JONATHAN", "executive_title": "Chief R&D Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5681.0, "share_price": 70.0, "transaction_value": 397670.0, "fetched_at": "2026-07-20T11:12:39.312350+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}, {"symbol": "NKTR", "name": "Nektar Therapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "ROBIN, HOWARD W", "executive_title": "Director, President & CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5500.0, "share_price": 60.81, "transaction_value": 334455.0, "fetched_at": "2026-07-13T11:14:26.737064+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}, {"symbol": "NKTR", "name": "Nektar Therapeutics", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-17", "executive": "ROBIN, HOWARD W", "executive_title": "Director, President & CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4500.0, "share_price": 61.65, "transaction_value": 277425.0, "fetched_at": "2026-07-13T11:14:26.738988+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/nktr/", "research_links": {"chart": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/", "report": "/terminal/2b54e02b-1441-43ca-8cf6-5798bc73166f/report/", "factor": "/factors/ticker/2b54e02b-1441-43ca-8cf6-5798bc73166f/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}